Literature DB >> 11140466

The role of cytokines in experimental autoimmune encephalomyelitis.

E Bettelli1, L B Nicholson.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an animal model of the demyelinating disease multiple sclerosis. In EAE cytokines play a critical role in defining the Th1 or Th2 nature of the autoantigen directed immune response, and in propagating and regulating inflammation within the central nervous system. In this review we summarize some of the recent developments in the field of cytokine research that relate to this model of human disease, focusing principally on disease induced with the autoantigens myelin proteolipid protein and myelin oligodendrocyte protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11140466

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  5 in total

1.  Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis.

Authors:  Ajaib S Paintlia; Manjeet K Paintlia; Inderjit Singh; Avtar K Singh
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

2.  Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamed white matter in an animal model of multiple sclerosis.

Authors:  Elimor Brand-Schieber; Peter Werner; Dumitru A Iacobas; Sanda Iacobas; Michelle Beelitz; Stuart L Lowery; David C Spray; Eliana Scemes
Journal:  J Neurosci Res       Date:  2005-06-15       Impact factor: 4.164

Review 3.  Inflammation in central nervous system injury.

Authors:  Stuart M Allan; Nancy J Rothwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-10-29       Impact factor: 6.237

4.  Dual gene therapy with extracellular superoxide dismutase and catalase attenuates experimental optic neuritis.

Authors:  Xiaoping Qi; William W Hauswirth; John Guy
Journal:  Mol Vis       Date:  2007-01-05       Impact factor: 2.367

5.  Plasma biomarkers discriminate clinical forms of multiple sclerosis.

Authors:  Marta Tejera-Alhambra; Armanda Casrouge; Clara de Andrés; Ansgar Seyfferth; Rocío Ramos-Medina; Bárbara Alonso; Janet Vega; Lidia Fernández-Paredes; Matthew L Albert; Silvia Sánchez-Ramón
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.